KALAMAZOO, Mich., Feb. 2 /PRNewswire-FirstCall/ -- Stryker Corporation announced today that it will conduct an Analyst Meeting on Wednesday, May 19, 2010, at 8:00 a.m. Eastern Time, in New York, New York.
A simultaneous webcast of the meeting will be available on Stryker’s website at www.stryker.com via the For Investors page. The webcast will be archived on this site for 90 days. To hear the meeting via telephone, dial 800-599-9795 (domestic) or 617-786-2905 (international) and enter registration number 78278854.
Certain statements made in the presentation may constitute forward-looking statements. They will be based upon management’s current expectations and will be subject to various risks and uncertainties that could cause the Company’s actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for the Company’s products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company’s products; changes in foreign exchange markets; legislative and regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; unfavorable resolution of tax audits; changes in financial markets; and changes in the competitive environment. Additional information concerning these and other factors is contained in the Company’s filings with the U.S. Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
Stryker Corporation
